STOCK TITAN

HNGE (HNGE) Bessemer Venture Partners files Form 144 for Class A stock sales

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Bessemer Venture Partners affiliates filed a Form 144 indicating planned sales of HNGE Class A shares. The notice covers 2,453 Class A shares to be sold through Merrill Lynch, with an aggregate market value of $122,453.76 and 37,919,155 Class A shares outstanding as context. The approximate sale date is listed as December 5, 2025 on the NYSE.

The securities to be sold were acquired in a private placement from the issuer on February 4, 2020 and paid for in cash. The filing also reports multiple prior Class A sales during November 2025 by Bessemer Venture Partners X LP and Bessemer Venture Partners X Institutional LP, including blocks of 373,955 and 351,045 shares, each generating multi‑million dollar gross proceeds.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the HNGE Form 144 filing by Bessemer Venture Partners disclose?

The Form 144 discloses that Bessemer Venture Partners affiliates plan to sell 2,453 Class A shares of HNGE through Merrill Lynch, with an aggregate market value of $122,453.76 and an approximate sale date of December 5, 2025 on the NYSE.

How many HNGE shares are outstanding according to this Form 144?

The Form 144 states that there are 37,919,155 Class A shares outstanding, providing a baseline for understanding the size of the planned sale relative to the total share count.

How and when did Bessemer acquire the HNGE shares covered by this Form 144?

The shares covered were acquired as Class A stock in a private placement from the issuer on February 4, 2020, with cash listed as the nature of payment for the 2,453 securities acquired on that date.

What prior HNGE share sales by Bessemer are reported in the last three months?

The filing lists several Class A sales during November 2025 by Bessemer entities, including Bessemer Venture Partners X LP selling 373,955 shares on November 18, 2025 for $14,976,898 in gross proceeds and Bessemer Venture Partners X Institutional LP selling 351,045 shares on the same date for $14,059,352.

Which broker and exchange are involved in the planned HNGE share sale?

The Form 144 lists Merrill Lynch, One Bryant Park, New York, NY 10036 as the broker and names the NYSE as the securities exchange for the planned sale of HNGE Class A shares.

What representation does the seller make about information on HNGE in this Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about HNGE’s current or prospective operations that has not been publicly disclosed.
Hinge Health, Inc.

NYSE:HNGE

HNGE Rankings

HNGE Latest News

HNGE Latest SEC Filings

HNGE Stock Data

3.79B
34.51M
8.08%
132.02%
1.61%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SAN FRANCISCO